XML 81 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements - Additional Information (Detail)
€ in Millions
12 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
EUR (€)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration $ 3,200,000 $ 11,041,000        
Contingent consideration liability, noncurrent   3,425,000        
Level 3 assets 0 0        
Transfers in or out Level 3, Assets 0 0        
Transfers in or out Level 3, Liabilities 0 $ 0        
Minimum [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Percentage of Probability Achievement of Contingent Consideration payment.   5.00%        
Maximum [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Percentage of Probability Achievement of Contingent Consideration payment.   95.00%        
Contingent Consideration [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Foreign currency gains (losses) $ 100,000 $ 100,000 $ (500,000)      
Contingent Consideration [Member] | Revenue Based Milestones [Member] | Discount Rate [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Fair value measurement inputs 20.5          
Contingent Consideration [Member] | Non Revenue Based Milestones | Discount Rate [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Fair value measurement inputs   6.0       6.0
Creagh Medical Ltd [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration related to acquisition   $ 11,000,000     $ 11,000,000 € 9.6
Business combination contingent consideration liability percentage 2.30%          
Scenario Forecast [Member] | NorMedix [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration related to acquisition       $ 3,200,000    
Level 3 Liabilities [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration $ 3,200,000          
Contingent consideration liability   14,500,000        
Contingent consideration liability, noncurrent   $ 3,400,000